Cannabis Law Report

JUNE 24, 2022

Minnesota; New Jersey; New York; Pennsylvania; and Washington all include provisions to give employees access to paid sick days and time off, as well as health insurance and retirement benefits. These gains, however, are not as accessible to minorities, who face barriers to entering the cannabis market.

Legislation 52

Legislation Cannabis Conditions Programs 52

CannaMD

MARCH 3, 2021

A recent peer-reviewed article published in the Journal of Drug Issues sought to provide quantitative data on the spillover effect , a term used to describe the influence of legalized marijuana on neighboring states. It’s important to note that the Washington data was more limited than the Colorado data.

Legalization 119

Legalization Marijuana Data Safety 119

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

SpeedWeed

AUGUST 22, 2021

The MS Society is taking a stand on the lack of progress and access to cannabis in the UK, especially since medical cannabis has been legal there for almost three years. deserves access to effective?treatments.” treatments.” . View original article. ApprovedButDenied.

Sleep 52

Sleep Access Patients Treatment 52

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. View original article.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

CannaMD

JANUARY 6, 2021

When it comes to marijuana legalization, one of the opposition’s main concerns is whether legal access to cannabis will increase the number of drivers who operate a vehicle in an impaired state. Early data shows that after legalization, Colorado experienced a slight increase in cases of people driving under the influence of cannabis.

Recreational 105

Recreational Marijuana Data Collective 105

Veriheal

MARCH 29, 2023

In addition, several other studies suggest that legalizing access to marijuana is actually associated with decreased: Crime Opioid overdose Mental illness rates Gone are the days when cautionary tales run rampant. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2 1, 2003, to Dec. 1, 2003, to Dec.

Legalization 57

Legalization Data Policy Cannabis 57

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

JANUARY 21, 2022

Supreme Court to hear her appeal over coverage of medical marijuana treatments, as reported in the article “ U.S. Full access to the complete content of Best’s Review is available here. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry.

Treatment 52

Treatment Data Business Access 52

Cannabis Law Report

JULY 25, 2022

This article will help you understand the laws in Pennsylvania. Medical marijuana is legal in Pennsylvania but it can be accessed only by registered patients with a medical marijuana card. Some of the conditions that qualify for receiving medical marijuana treatment in Pennsylvania include, but are not limited to: Muscle spasticity.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

SpeedWeed

MARCH 13, 2021

However, common treatments do not address the non-motor symptoms and can sometimes cause side effects including dyskinesia, an abnormality or impairment of voluntary movement. . As a result, many patients turn to complementary or alternative treatments for their disease. . One such alternative treatment is cannabis.

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

APRIL 12, 2019

Here’s the article and it is the first time we’ve seen a piece providing a proper analysis of what is, or should we say, isn’t happening in Australia with regard to cannabis and a workable regulated envirojment. While medicinal cannabis products are available, they’re not easily accessible. They write.

Recreational 45

Recreational Access Legislation Programs 45

Veriheal

SEPTEMBER 15, 2021

This is very important if we wish to see a day where cannabis has been removed from harsh drug scheduling and if we wish to see it become part of everyday treatment practices by professionals. . Non-Experimental Research: Observational study, or non-experimental research, focuses on analyzing data in its natural context.

Data 95

Data Collective Environment Cannabis 95

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Healer

MARCH 26, 2021

This article was originally published in the Portland Press Herald. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. March 19, 2021. Others aren’t so sure.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

SpeedWeed

APRIL 6, 2021

The use of cannabis by patients enrolled in a methadone maintenance treatment program is associated with fewer nonfatal opioid overdoses, according to the results of a recently published study. View original article.

Patients 52

Patients Advocacy Treatment Data 52

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. In March, 2016, State Bill 307 expanded access to full-strength medical marijuana to terminally ill patients who were determined by two doctors to have less than a year to live.

Law 126

Law Marijuana Patients Treatment 126

SpeedWeed

MAY 22, 2021

This work builds capacity to deliver quality, accessible care to patients, pending approval of MDMA-assisted therapy as a legal prescription treatment.”. Fortunately, MAPS has already conducted several clinical studies confirming that this treatment is both safe and effective. View original article.

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 24, 2022

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. In this article we elaborate on the requirements under which psychedelics may be used in Switzerland today. CV | More articles. CV | More articles.

Research and Development 52

Research and Development Legalization Treatment Patients 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). Le-Short C.,

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to provide appropriate research data. Explanation of how the proposed dispensary location expands access to patients and caregivers. Criterion 5. Criterion 7. 100 pts .

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

AUGUST 19, 2019

To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. No data is available regarding prescriptions written in respect of secondary care. The content of this article is intended to provide a general guide to the subject matter. Novel Foods Regulation.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

JULY 6, 2021

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist, an effective treatment for alcoholism. ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

The Cannigma

AUGUST 5, 2022

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

SEPTEMBER 9, 2021

The collection of data for the final study was through focused interviews with a snowball sample of eight participants who have experienced trying to enter the cannabis industry in Western City, California. Data were analyzed based on the central question, and three themes emerged. Theme 3 involved access to capital.

Policy 105

Policy Research and Development Collective Banking 105

Veriheal

MAY 3, 2022

Kevin Potter taking responsibility for the integrity and accuracy of the data. a necessary question to address as medical marijuana becomes more accessible. The study also said that the participants could continue their usual treatments or psychiatric care but did not specify which conditions the patients had.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

The Cannigma

JULY 6, 2022

Cultivars included in this article: Canna-Tsu Bubba Kush Critical Mass Stephen Hawking Kush Harlequin Harmony Rose. Moreover, some people don’t find Type II cannabis to be sedating enough or simply don’t have access to this type of product, in which case moving to a THC-dominant product is appropriate. How cannabis can help with sleep.

Sleep 117

Sleep Terpenes Strains Chronic Pain 117

Cannabis Law Report

DECEMBER 21, 2021

The rapid increase in the volume of enterprise data and growing automation of business processes across several end-use industries such as retail, manufacturing, healthcare, and transportation are expected to drive the demand for business software and services over the forecast period. billion in 2020 (Grandview Research). from 2021 to 2028.

Research and Development 52

Research and Development Supply Chain Data Business 52

MMJ Recs

FEBRUARY 23, 2024

This article delves into the multifaceted economic impact of the burgeoning medical marijuana industry in Michigan, exploring various facets such as business growth, financial contributions, employment opportunities, market trends, and the broader implications for local economies.

Marijuana 52

Marijuana Dispensary Research and Development Supply Chain 52

Cannabis Law Report

JULY 30, 2019

For now, both Florida’s restrictions and federal restrictions on the scheduling of cannabis still apply as states scramble to formulate respective regulations for research, access, education, innovation. There is a distinct lack of past aggregated credible, published, accessible ongoing research or case studies.

Marijuana 40

Marijuana Education Patients Research and Development 40

Freedom Leaf

JANUARY 4, 2018

After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. ” JOHN KAGIA. ” OPHELIA CHONG.

Data 60

Data Policy Media Cannabis 60

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

APRIL 14, 2022

Before legalization, illicit grow sites did not have access to water utilities and were typically grown in arid/remote areas, often depleting local surface water and shallow aquifers not suited to intensive use. Nothing in this article constitutes professional legal advice nor is intended to be a substitute for professional legal advice.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

FEBRUARY 17, 2020

The Committee will convene telephonically and in-person bimonthly to develop ways and methods to expand patient access and affordability, increase innovation and technology within the cannabis industry, and to make recommendations to the Legislature and the Department of Health’s Office of Medical Marijuana Use (OMMU).

Dispensary 76

Dispensary Patients Agriculture Conditions 76